Explore Intellia Therapeutics, Inc.'s outlook after Phase 3 trial concerns. See how FDA decisions may impact CRISPR therapy ...
When blood cancer in children progresses particularly aggressively, it is often due to a genetic defect: a gene fusion, such ...
From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a ...
Modern Engineering Marvels on MSN
CRISPRi unveils tuberculosis’ fatal respiratory weak point
A disease that has stalked humanity for millennia may have finally met its match. Mycobacterium tuberculosis, the pathogen ...
New gene-editing tools – most notably the Nobel Prize-winning CRISPR-Cas9 – allow targeted tweaks to a crop’s genome, ...
Preliminary results from two trials of the gene therapy exagamglogene autotemcel (exa-cel) suggest the therapy offers an effective cure for beta-thalassemia and sickle cell disease in children younger ...
Kennesaw State University senior biology major Ari Schwartz has been recognized with the President’s Award of Distinction and ...
5d
Sana Biotechnology, Inc. (SANA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Citi Annual Global Healthcare Conference 2025 December 2, 2025 2:30 PM ESTCompany ParticipantsSteven Harr - President, ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
Casgevy, now a "national priority" drug, helped kids with sickle cell and thalassemia, results which may help toward a label ...
News-Medical.Net on MSN
CRISPR-based Cellgorithm technology ushers in a new era of cell programming
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback